WOCKPHARMA Wockhardt Ltd Product Launches Announcement 2024 - New Antibiotic Launch Wockhardts new antibiotic WCK 6777 has received Fast Track designation from the US FDA after successfully completing a Phase I study with 52 participants, showing a promising safety profile for treating drug-resistant infections..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd